GE Healthcare Life Sciences is focused on supporting a rapidly changing biopharma ecosystem, advancing how future therapeutics are discovered and commercialized.
Whatever your strategy, we’re here to help. From accelerating speed to market, innovation, or efficiency, we look forward to combining our expertise with yours to bring future medicines to market.
Schedule an in-person meeting to discuss your development and manufacturing needs and how we can collaborate for your success.
Join the FlexFactory tour! Register for the Jefferson Institute of Bioprocessing tour in partnership with NIBRT and see how real-world hands-on training is delivered.
Manufacturing capacity within 18 months
Invest after Phase III with lower risk and be market ready with modular facilities. Learn more about the KUBio modular facility.
Buy, build or partner?
Quantify and manage uncertainty with optionality – an analytical tool that can help you make better decisions. Learn more
Mitigate risk and accelerate outcomes
Check the pulse of your organization and determine when outsourcing makes sense for your overall strategy.
Alternatives to conventional development
Collaboration with CCRM brings scalable manufacturing to novel molecules.
Five-year partnership between Vanderbilt University Medical Center and GE Healthcare will enable safer and more precise cancer immunotherapies.
Optimize purification parameters and gain efficiency using innovative Fibro technology for chromatography.
1% efficiency gains save millions
Data from raw materials and process equipment identifies key parameters that effect yield. A one percent efficiency gain can net more than $1.2 M and dramatically improve efficiency. Analytics is the key to unlocking savings.
Supply chain advancements for raw materials help identify areas for efficiency gains. Learn how we helped Amgen.
GE Healthcare and Rockwell Automation collaborate to streamline production technologies and adaptable manufacturing environments.
We discover, partner, and integrate external technology. Developing GE’s innovation pipeline with the best companies, ideas and external technology. Put your ideas to work–grow with GE. If you would like to meet with GE at BIO 2019, contact us at [email protected]
Parallel processing gives you the option to work with a CDMO and delay the decision of which biomanufacturing solution might work best. Drug development is inherently risky. Every decision can make or break a project, and, unfortunately, many are made long before anyone knows if the drug will make it to market.
Gaining a skilled labor force in the growing biopharma industry can be a challenge. So what strategies should your company be considering for recruiting, training and retaining qualified bioprocessing candidates. Discover how you can upskill staff in cell therapy manufacturing.